This review summarizes the interactions of the methylene dioxyphenyl or benzodioxole function with cytochrome P450 and their toxicological and pharmacokinetic implications. The methylenedioxy group is a common group in natural and synth,etic medicinal compounds and provides an electronegative function that •is relatively unreactive and non polar. The function is oxidized by cytochrome P450 to form a catechol and T formate or carbon monooxide or alternatively, forms a complex with the heme iron of cytochrome P450. This complex, characterized by its absorption in the 455 nm range, can be very stable and inhibits the catalytic cycle of the enzyme. This inhibitory action has been used to enhance the actions of insecticides and has been the basis for pharmacokinetic drug interactions, The catechol product of benzodioxole ring cleavage is redox active and can participate in quinone reactive oxygen based toxicity. The chemical basis for these interactions are proposed together with experimental ob ervations reported in the recent literature. Examples of pharmacokinetic drug interactions are also included.